Ad
ALT Quote Trading Chart Altimmune Inc.
Quote | Altimmune Inc. (NASDAQ:ALT)
| Last: | $6.89 |
|---|---|
| Change Percent: | 0.29% |
| Open: | $6.85 |
| Close: | $6.89 |
| High: | $6.97 |
| Low: | $6.645 |
| Volume: | 4,078,284 |
| Last Trade Date Time: | 06/17/2025 03:40:42 pm |
Quotes are delayed by 15 to 20 minutes.
ALT Last Twenty Trading Days
| Last | Open | Close | High | Low | Volume | Date |
|---|---|---|---|---|---|---|
| $6.89 | $6.85 | $6.89 | $6.97 | $6.645 | 4,078,284 | 06-17-2025 |
| $6.87 | $7.09 | $6.87 | $7.37 | $6.79 | 4,153,061 | 06-16-2025 |
| $6.92 | $6.94 | $6.92 | $7.405 | $6.75 | 4,336,494 | 06-13-2025 |
| $7.15 | $6.5 | $7.15 | $7.48 | $6.38 | 6,645,814 | 06-12-2025 |
| $6.54 | $6.79 | $6.54 | $7.08 | $6.52 | 3,852,624 | 06-11-2025 |
| $6.74 | $6.07 | $6.74 | $6.97 | $6.05 | 7,966,504 | 06-10-2025 |
| $5.95 | $5.75 | $5.95 | $5.96 | $5.57 | 2,766,169 | 06-09-2025 |
| $5.62 | $5.48 | $5.62 | $5.805 | $5.47 | 3,875,228 | 06-06-2025 |
| $5.46 | $5.5 | $5.46 | $5.6554 | $5.38 | 2,309,612 | 06-05-2025 |
| $5.49 | $5.39 | $5.49 | $5.57 | $5.335 | 4,201,575 | 06-04-2025 |
| $5.42 | $5.37 | $5.42 | $5.525 | $5.29 | 2,502,769 | 06-03-2025 |
| $5.3 | $5.46 | $5.3 | $5.52 | $5.15 | 2,508,820 | 06-02-2025 |
| $5.43 | $5.5 | $5.43 | $5.585 | $5.35 | 3,980,867 | 05-30-2025 |
| $5.61 | $5.56 | $5.61 | $5.74 | $5.4218 | 1,416,176 | 05-29-2025 |
| $5.49 | $5.52 | $5.49 | $5.555 | $5.38 | 1,424,792 | 05-28-2025 |
| $5.51 | $5.77 | $5.51 | $5.805 | $5.48 | 2,435,370 | 05-27-2025 |
| $5.71 | $5.63 | $5.77 | $5.79 | $5.62 | 1,652,579 | 05-26-2025 |
| $5.71 | $5.63 | $5.71 | $5.79 | $5.62 | 1,652,579 | 05-23-2025 |
| $5.77 | $5.59 | $5.77 | $5.915 | $5.5437 | 1,470,105 | 05-22-2025 |
| $5.59 | $5.73 | $5.59 | $5.945 | $5.54 | 2,179,614 | 05-21-2025 |
News, Short Squeeze, Breakout and More Instantly...
Altimmune Inc. Company Name:
ALT Stock Symbol:
NASDAQ Market:
0.29% G/L:
$6.89 Last:
4,078,284 Volume:
$6.85 Open:
$6.89 Close:
Altimmune Inc. Website:
Ad
-
GAITHERSBURG, Md., June 13, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced an oral presentation and three poster presentations on pemvid...
-
2025-06-10 14:01:40 ET Comtech Telecommunications Falls 18% on Contract Wind-Downs and Wider Losses Comtech Telecommunications Corp. ( CMTL ) fell 17.72% to lead declines in the PRISM Emerging Space Index after reporting Q3 results that reflected continued challenges in its ...
-
GAITHERSBURG, Md., May 19, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced that it has enrolled the first subject in the RECLAIM Phase 2 tria...